Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,605 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Microcalcification crystallography as a potential marker of DCIS recurrence.
Gosling SB, Arnold EL, Davies SK, Cross H, Bouybayoune I, Calabrese D, Nallala J, Pinder SE, Fu L, Lips EH, King L, Marks J, Hall A, Grimm LJ, Lynch T, Pinto D, Stobart H, Hwang ES, Wesseling J, Geraki K, Stone N, Lyburn ID, Greenwood C, Rogers KD; Grand Challenge PRECISION Consortium. Gosling SB, et al. Among authors: lynch t. Sci Rep. 2023 Jun 8;13(1):9331. doi: 10.1038/s41598-023-33547-8. Sci Rep. 2023. PMID: 37291276 Free PMC article.
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.
Strand SH, Houlahan KE, Branch V, King LM, Lynch T, Rivero-Guitiérrez B, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, DeMichele A, King T, McAuliffe P, Curtis C, Owzar K, Marks JR, Colditz GA, Hwang ES, West RB. Strand SH, et al. Among authors: lynch t. Breast Cancer Res. 2024 Sep 2;26(1):127. doi: 10.1186/s13058-024-01885-8. Breast Cancer Res. 2024. PMID: 39223670 Free PMC article.
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH; COMET Study Investigators. Hwang ES, et al. Among authors: lynch t. JAMA. 2025 Mar 18;333(11):972-980. doi: 10.1001/jama.2024.26698. JAMA. 2025. PMID: 39665585 Free PMC article. Clinical Trial.
Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study.
Rosenberg SM, Rushing C, Schreiber KL, Crowell KA, Bedrosian I, Hughes KS, Lynch T, Basila D, Collyar D, Frank ES, Darai S, Lanahan C, Marks JR, Plichta JK, Hyslop T, Thompson AM, Partridge AH, Hwang ES. Rosenberg SM, et al. Among authors: lynch t. Ann Surg Oncol. 2025 Jul 27. doi: 10.1245/s10434-025-17915-4. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40715630
Correction: Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.
Strand SH, Houlahan KE, Branch V, King LM, Lynch T, Rivero-Guitiérrez B, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, DeMichele A, King T, McAuliffe P, Curtis C, Owzar K, Marks JR, Colditz GA, Hwang ES, West RB. Strand SH, et al. Among authors: lynch t. Breast Cancer Res. 2025 Aug 26;27(1):153. doi: 10.1186/s13058-025-02106-6. Breast Cancer Res. 2025. PMID: 40859290 Free PMC article. No abstract available.
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.
Partridge AH, Hyslop T, Rosenberg SM, Bennett AV, Drier S, Jonsson M, Shimada A, Li Y, Li Y, Lynch T, Frank E, Collyar D, Basila D, Pinto D, Weiss A, Wolf A, Norris K, Witten M, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Darai S, Carey L, Thompson A, Hwang ES; COMET Study Consortium. Partridge AH, et al. Among authors: lynch t. JAMA Oncol. 2025 Mar 1;11(3):300-309. doi: 10.1001/jamaoncol.2024.6556. JAMA Oncol. 2025. PMID: 39665588 Clinical Trial.
1,605 results